Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase

Journal of Perinatology

Volumn 20, Issue 4, 2000, Pages 213-216

  Davis, Jonathan M ^a   Richter, Susan E ^a   Biswas, Saumitra ^a   Rosenfeld, Warren N ^a   Parton, Lance ^b   Gewolb, Ira H ^c   Parad, Richard ^d   Carlo, Waldemar ^e   Couser, Robert J ^f   Baumgart, Stephen ^g   Atluru, Vijaya ^a   Salerno, Lisa ^h   Kassem, Nadim ^h  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^g THOMAS JEFFERSON UNIVERSITY   (United States)

^h Bio Technology General Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE DISMUTASE;

ARTICLE; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; FEMALE; FOLLOW UP; GENETIC RECOMBINATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG DYSPLASIA; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PILOT STUDY; PREMATURITY; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; TIME;

ADMINISTRATION, INHALATION; BRONCHOPULMONARY DYSPLASIA; CONTROLLED CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MALE; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; RECOMBINATION, GENETIC; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK ASSESSMENT; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 0034201693     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200363     Document Type: Article

References (17)

1. Davis JM, Rosenfeld WN. Chronic lung disease. In: Avery GB, Fletcher MA, MacDonald MD, editors. Neonatology. Philadelphia; JB Lipincott; 1994. p. 453-77.
2. Singer L, Yamashita T, Lilien L, Collin M, Baley J. A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. Pediatrics 1997;100:987-93.
3. Volpe JJ. Brain injury in the premature infant: from pathogenesis to prevention. Brain Dev 1997;19:519-34.
4. Davis JM, Rosenfeld WN, Sanders RJ, Gonenne A. Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. J Appl Physiol 1993; 74:2234-41.
5. Turrens JF, Crapo JD, Freeman BA. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 1984;73:87-95.
6. Padmanabhan RV, Gudapaty R, Liener JE, Schwartz BA, Hoidal JR. Protection against oxygen toxicity by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase. Am Rev Respir Dis 1985;132:164-7.
7. Ment LR, Stewart WB, Duncan CC. Beagle puppy model of intravenuicular hemorrhage. J Neurosurg 1985;62:563-9.
8. Rosenfeld WN, Davis JM, Parton L, et al. Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1996;97:811-7.
9. Davis JM, Rosenfeld WN, Richter SE, et al. Safety and pharmacokinetics of multiple doses of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1997;100:24-30.
10. Palta M, Sadek M, Barnet JH, et al. Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. J Pediatr 1998;132:57-63.
11. Saugstad OD. Oxygen radical disease in neonatology. Semin Neonatol 1998;3: 231-8.
12. Rosenfeld WN, Davis JM. Prevention of oxygen radical disease in the newborn: possible therapeutic approaches. Semin Neonatal 1998;3:239-44.
13. Keszler M, Modanlou HD, Brudno DS, et al. Multicenter, controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome. Pediatrics 1997;100:593-9.
14. Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 1998;101:E7.
15. Pourcyrous M, Leffler CW, Mirro R, Busija DW. Brain superoxide anion generation during asphyxia and reventilation in newborn pigs. Pediatr Res 1990;28: 618-21.
16. Kirsch JR, Helfaer MA, Haun SE, Koehler RC, Traystman RJ. Polyethylene glycolconjugated superoxide dismutase improves recovery of postischemic hypercapnic cerebral blood flow in piglets. Pediatr Res 1993;34:530-7.
17. Davis JM, Rosenfeld WW, Richter SE, et al. The effects of multiple doses of recombinant human superoxide dismutase in premature infants with respiratory distress syndrome. Pediatr Res 1999;45:193A.